Intraday News Mover:: BioCryst Pharmaceuticals, Inc., (NASDAQ: BCRX)

 

On Monday, November 16, 2020, the Company, BioCryst Pharmaceuticals, Inc., BCRX stock construct a change of 0.91 percent (Gain) in a total of its share price and having its trading value $4.45, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $757.21M with the total Outstanding Shares of 176.52M.

 


P/S, P/E, P/B & P/C values of (NASDAQ: BCRX):

 

BioCryst Pharmaceuticals, Inc. institutional ownership is standing at 77.5 percent, while insider ownership is 0.1 percent. As of now, BCRX has a P/S, P/E and, P/B values of 14.15, 0, and 23.42 respectively. Its P/Cash is valued at 5.28.

 

The stock SMA50 is now at 16.71 percent. In looking, the SMA 200 we see that the stock has seen a 17.73 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 92.2 percent.


Profitability ratios:

 

Looking into the profitability ratios of BCRX stock, an investor will find its ROE, ROA, ROI standing at -328.7 percent, -71.1 percent and, -84.1 percent, respectively.


Beta Factor:

 

A beta factor is used to measure the volatility of the stock. The stock remaining at 5.54 percent volatile for the week and 6.45 percent for the month.


Gross / Operating Margins of BCRX:

 

It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 92.2 percent & Operating Margin seen at 0 percent.


Target Price:

 

Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company BioCryst Pharmaceuticals, Inc. recorded it at $0.


Historical Performance In The News:

 

Taking a look at the performance of BioCryst Pharmaceuticals, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 14.69 percent, resulting in a performance for the month at 15.73 percent.

Therefore, the stated figure displays a quarterly performance of -1.33 percent, bringing six-month performance to -12.75 percent and year to date performance of 28.99 percent. As of now, BioCryst Pharmaceuticals, Inc. has a P/S, P/E and, P/B values of 14.15, 0, and 23.42 respectively. Its P/Cash is valued at 5.28.


Earnings per Share Details of BioCryst Pharmaceuticals, Inc.:

 

The EPS of BCRX is strolling at -0.76, measuring its EPS growth this year at 4 percent. As a result, the company has an EPS growth of 10.4 percent for the approaching year.